{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:24:25Z","timestamp":1791606265389,"version":"4.3.4"},"reference-count":102,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2024,6,2]]},"DOI":"10.1080\/14712598.2024.2370397","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T08:45:59Z","timestamp":1718786759000},"page":"491-502","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Antibody-based therapeutics for chronic rhinosinusitis with nasal polyps"],"prefix":"10.1080","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3880-1183","authenticated-orcid":false,"given":"Shama","family":"Shishodia","sequence":"first","affiliation":[{"name":"Department of Rhinology and Skull Base Surgery, Guy\u2019s and St Thomas\u2019 Hospital NHS, Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Haloob","sequence":"additional","affiliation":[{"name":"Department of Rhinology and Skull Base Surgery, Guy\u2019s and St Thomas\u2019 Hospital NHS, Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hopkins","sequence":"additional","affiliation":[{"name":"Department of Rhinology and Skull Base Surgery, Guy\u2019s and St Thomas\u2019 Hospital NHS, Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"issue":"3","key":"e_1_3_4_3_1","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2012","volume":"23","author":"Fokkens WJ","year":"2012","unstructured":"Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012;23(3): preceding table of contents. 1\u2013298.","journal-title":"Rhinol Suppl"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S372598"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1800215"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2021.789425"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.12.482"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-4486.2006.01275.x"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.09.009"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/000348940311200709"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/00016480252814199"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.06.037"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/coa.14070"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21695"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S86251"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.09.063"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin21.264"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.04.040"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S258438"},{"key":"e_1_3_4_20_1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"103","author":"Fokkens WJ","unstructured":"Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Dieudonn\u00e9 Nyenbue Tshipukane. 103.","journal-title":"Dieudonn\u00e9 Nyenbue Tshipukane"},{"key":"e_1_3_4_21_1","first-page":"CD011992","article-title":"Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis","volume":"4","author":"Head K","year":"2016","unstructured":"Head K, Chong LY, Hopkins C, et al. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4:CD011992.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011991.pub2"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.5.1468"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0151-2019"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.20653"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.20101"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.2500\/ajr.2007.21.3073"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000230399.24306.50"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.26391"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-019-0303-6"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2014.12.006"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201412-2278OC"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01225.x"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12878"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013513.pub3"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.05.032"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00097-7"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31881-1"},{"key":"e_1_3_4_39_1","unstructured":"Dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal) [Internet]. [cited 2023 Oct 3]. Available from: https:\/\/www.nice.org.uk\/guidance\/ta648\/resources\/dupilumab-for-treating-chronic-rhinosinusitis-with-nasal-polyps-terminated-appraisal-pdf-82609144907461"},{"key":"e_1_3_4_40_1","unstructured":"Omalizumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal) [Internet]. [cited 2023 Oct 3]. Available from: https:\/\/www.nice.org.uk\/guidance\/ta678\/resources\/omalizumab-for-treating-chronic-rhinosinusitis-with-nasal-polyps-terminated-appraisal-pdf-82609326305989"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1323896111"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1298443"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9091096"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.09.027"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16040630"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22028"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/0194599818773065"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.14152"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.08.030"},{"key":"e_1_3_4_50_1","unstructured":"FDA declines approval for AstraZeneca\u2019s chronic rhinosinusitis antibody [Internet]. 2022 [cited 2023 Oct 2]. Available from: https:\/\/www.pharmaceutical-technology.com\/news\/fda-astrazeneca-rhinosinusitis-antibody\/?cf-view&cf-closed"},{"key":"e_1_3_4_51_1","unstructured":"NCT04157335. [Internet] https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04157335"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.08.021"},{"key":"e_1_3_4_53_1","unstructured":"Randomised A. Double-blind parallel group phase III study to assess the efficacy and safety of 100 mg SC depemokimab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) \u2013 ANCHOR-1 (depemokimAb in CHrOnic rhinosinusitis) [Internet]. [cited 2023 Oct 2]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05274750"},{"key":"e_1_3_4_54_1","unstructured":"Randomised A. Double-blind parallel group phase iii study to assess the efficacy and safety of 100 mg SC depemokimab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) - ANCHOR-2 (depemokimAb iN CHronic rhinosinusitis) [Internet]. [cited 2023 Oct 2]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05281523"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01503-z"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S413064"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.12.058"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-023-00602-9"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax2945"},{"key":"e_1_3_4_60_1","unstructured":"A phase 2 double-blind placebo-controlled parallel group multiple dose study to investigate etokimab (ANB020) in adult subjects with chronic rhinosinusitis with nasal polyposis [Internet]. [cited 2023 Oct 2]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03614923?cond=nasal%20polyps%20&term=etokimab&rank=1&tab=results"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1159\/000519228"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.05.019"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.12169"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00685-0"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2021.2008431"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2022.103615"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI129697"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24763-9"},{"key":"e_1_3_4_69_1","unstructured":"Drug safety update latest advice for medicines users. Contents [Internet]. 2022 Nov;16(4). Available from: https:\/\/www.gov.uk\/government\/organis"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.038"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.305452"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes353"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00457-4"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13875"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/coa.13779"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin22.489"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.23249"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22851"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.14809"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-1-80"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22936"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.28648"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22865"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006680"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.29911"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.15134"},{"key":"e_1_3_4_87_1","article-title":"A case of intractable chronic rhinosinusitis without nasal polyps leading remission after treatment switching from anti-IL-5 to anti-IL-4R\u03b1 monoclonal antibody","volume":"27","author":"Oka SI","year":"2023","unstructured":"Oka SI, Kanai K, Oka A, et al. A case of intractable chronic rhinosinusitis without nasal polyps leading remission after treatment switching from anti-IL-5 to anti-IL-4R\u03b1 monoclonal antibody. Otolaryngol Case Rep. 2023:27.","journal-title":"Otolaryngol Case Rep"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.05.009"},{"key":"e_1_3_4_89_1","article-title":"The diagnostic and prognostic role of biomarkers in chronic rhinosinusitis","volume":"13","author":"Seah JJ","year":"2023","unstructured":"Seah JJ, Thong M, Wang DY. The diagnostic and prognostic role of biomarkers in chronic rhinosinusitis. Diagnostics (Basel) [Internet]. 2023 [cited 2023 Dec 19];13. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36832203\/","journal-title":"Diagnostics (Basel)"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.08.036"},{"key":"e_1_3_4_91_1","unstructured":"Roy A. Biologic medicines: the biggest driver of rising drug prices [Internet]. [cited 2023 Oct 2]. Available from: https:\/\/www.forbes.com\/sites\/theapothecary\/people\/aroy\/?sh=4c2d5da52496"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22780"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.23246"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.006"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00082"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411776"},{"key":"e_1_3_4_97_1","unstructured":"A phase 3 double-blind randomized 8-week vehicle-controlled efficacy and safety study of ruxolitinib cream followed by a long-term safety extension period in adolescents and adults with atopic dermatitis [Internet]. [cited 2023 Oct 5]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03745638"},{"key":"e_1_3_4_98_1","unstructured":"An Open-label. Clinical study to evaluate the safety and tolerability of treprostinil inhalation powder (TreT) in subjects with pulmonary arterial hypertension currently using tyvaso [Internet]. [cited 2023 Oct 5]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03950739"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.29129"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105523"},{"key":"e_1_3_4_101_1","unstructured":"A Two-part Phase IIa Randomised. Double-blind placebo-controlled dose-ranging multi-centre study to assess efficacy and safety of inhaled AZD1402 administered as a dry powder for four weeks in adults with asthma on medium-to-high dose inhaled corticosteroid [Internet]. [cited 2023 Oct 2]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04643158"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0314-6"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13677"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2017.03.00"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2024.2370397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T11:56:27Z","timestamp":1728561387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2024.2370397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,2]]},"references-count":102,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,2]]}},"alternative-id":["10.1080\/14712598.2024.2370397"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2024.2370397","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-10-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}